BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17593975)

  • 21. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.
    van den Bent MJ; Looijenga LH; Langenberg K; Dinjens W; Graveland W; Uytdewilligen L; Sillevis Smitt PA; Jenkins RB; Kros JM
    Cancer; 2003 Mar; 97(5):1276-84. PubMed ID: 12599236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
    Gravendeel LA; Kouwenhoven MC; Gevaert O; de Rooi JJ; Stubbs AP; Duijm JE; Daemen A; Bleeker FE; Bralten LB; Kloosterhof NK; De Moor B; Eilers PH; van der Spek PJ; Kros JM; Sillevis Smitt PA; van den Bent MJ; French PJ
    Cancer Res; 2009 Dec; 69(23):9065-72. PubMed ID: 19920198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
    Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
    Born PW; Broholm H; Laursen H
    Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: a combined comparative genomic hybridization and microsatellite analysis.
    Zahn S; Sievers S; Alemazkour K; Orb S; Harms D; Schulz WA; Calaminus G; Göbel U; Schneider DT
    Genes Chromosomes Cancer; 2006 Nov; 45(11):995-1006. PubMed ID: 16897744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
    Jha P; Agarwal S; Pathak P; Srivastava A; Suri V; Sharma MC; Chosdol K; Srivastava T; Gupta D; Gupta A; Suri A; Sarkar C
    Cancer Genet Cytogenet; 2010 Apr; 198(2):126-34. PubMed ID: 20362227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas.
    Kujas M; Lejeune J; Benouaich-Amiel A; Crinière E; Laigle-Donadey F; Marie Y; Mokhtari K; Polivka M; Bernier M; Chretien F; Couvelard A; Capelle L; Duffau H; Cornu P; Broët P; Thillet J; Carpentier AF; Sanson M; Hoang-Xuan K; Delattre JY
    Ann Neurol; 2005 Aug; 58(2):322-6. PubMed ID: 16049942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy.
    Mariani L; Deiana G; Vassella E; Fathi AR; Murtin C; Arnold M; Vajtai I; Weis J; Siegenthaler P; Schobesberger M; Reinert MM
    J Clin Oncol; 2006 Oct; 24(29):4758-63. PubMed ID: 16966689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
    Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A;
    Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort.
    Pollack IF; Finkelstein SD; Burnham J; Hamilton RL; Yates AJ; Holmes EJ; Boyett JM; Finlay JL
    Pediatr Neurosurg; 2003 Sep; 39(3):114-21. PubMed ID: 12876389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.
    Zhao J; Ma W; Zhao H
    Neuro Oncol; 2014 Jan; 16(1):103-12. PubMed ID: 24311641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas.
    Thon N; Eigenbrod S; Grasbon-Frodl EM; Ruiter M; Mehrkens JH; Kreth S; Tonn JC; Kretzschmar HA; Kreth FW
    J Neuropathol Exp Neurol; 2009 Nov; 68(11):1219-28. PubMed ID: 19816195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
    Maris JM; Guo C; Blake D; White PS; Hogarty MD; Thompson PM; Rajalingam V; Gerbing R; Stram DO; Matthay KK; Seeger RC; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):32-6. PubMed ID: 11464900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors.
    Iuchi T; Namba H; Iwadate Y; Shishikura T; Kageyama H; Nakamura Y; Ohira M; Yamaura A; Osato K; Sakiyama S; Nakagawara A
    Genes Chromosomes Cancer; 2002 Oct; 35(2):170-5. PubMed ID: 12203781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosome 1p and 19q evaluation in low-grade oligodendrogliomas: a descriptive study.
    Molinari C; Iorio P; Medri L; Ballardini M; Guiducci G; Cremonini AM; Cerasoli S; Riccioni L; Faedi M; Mariani GA; Zoli W; Silvestrini R; Calistri D
    Int J Mol Med; 2010 Jan; 25(1):145-51. PubMed ID: 19956913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.
    Ino Y; Zlatescu MC; Sasaki H; Macdonald DR; Stemmer-Rachamimov AO; Jhung S; Ramsay DA; von Deimling A; Louis DN; Cairncross JG
    J Neurosurg; 2000 Jun; 92(6):983-90. PubMed ID: 10839259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Towards a molecular classification of gliomas].
    Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
    Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gliomas: association of histology and molecular genetic analysis of chromosomes 1p, 10q, and 19q.
    Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Sikorska B; Papierz W; Liberski PP
    Acta Neurobiol Exp (Wars); 2007; 67(2):103-12. PubMed ID: 17691218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.